Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05939453 · ClinicalTrials.gov registry record · NA

Impact of Bright Light Therapy on Prader-Willi Syndrome

A NA study of Mood and Body Weight, sponsored by Maimonides Medical Center.

Recruiting
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT05939453 is a NA study of Mood and Body Weight that is actively recruiting participants, run by Maimonides Medical Center. The registered enrollment target is 30 participants, below the 3,659-participant average among 29 other Mood trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05939453, a NA study of Mood and Body Weight, is actively recruiting participants, sponsored by Maimonides Medical Center.

RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

This is a placebo controlled clinical trial to assess the utility of light therapy as a sufficient treatment for excessive daytime sleepiness in patients with Prader-Willi Syndrome

Interventions

  • OTHER Sham Light
  • OTHER Bright Light Therapy

Study Locations (1)

New York

  • Maimonides Medical Center - Brooklyn

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2023-10-01
Est. Completion 2026-06
Phase NA

Sponsor

Maimonides Medical Center

39 total trials

What the Registry Record Tells You About NCT05939453

The ClinicalTrials.gov registry entry for NCT05939453 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,659-participant average among 29 other Mood trials with a reported enrollment target (99% lower). The listed sponsor is Maimonides Medical Center, which has 39 total studies on file at ClinicalTrials.gov.

The record links to 6 conditions, with Mood appearing as the primary indexed condition, and to 2 interventions - of which Sham Light is the first listed.

NCT05939453 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT05939453 about?

NCT05939453 is a clinical study titled "Impact of Bright Light Therapy on Prader-Willi Syndrome". This is a placebo controlled clinical trial to assess the utility of light therapy as a sufficient treatment for excessive daytime sleepiness in patients with Prader-Willi Syndrome

What is the current status of trial NCT05939453?

This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2023-10-01. Estimated completion is 2026-06.

What conditions does trial NCT05939453 study?

This clinical trial studies the following conditions: Mood, Body Weight, Behavior, Prader-Willi Syndrome, Excessive Daytime Sleepiness.

What interventions are being tested in trial NCT05939453?

The interventions under investigation include: Sham Light (OTHER), Bright Light Therapy (OTHER).

Who is sponsoring clinical trial NCT05939453?

This trial is sponsored by Maimonides Medical Center, which has 39 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05939453 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Mood

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.